Impact of Rotavirus Vaccine Introduction and Vaccine Effectiveness in the Republic of Moldova

Clinical Infectious Diseases

Volumn 62, Issue , 2016, Pages S140-S146

  Gheorghita, Stela ^a   Birca, Ludmila ^b   Donos, Ala ^c   Wasley, Annemarie ^d   Birca, Ion ^a   Cojocaru, Radu ^a   Melnick, Anatol ^a   Ciobanu, Silviu ^d   Mosina, Liudmila ^d   Cortese, Margaret M ^e   Parashar, Umesh D ^e   Lopman, Ben ^e  

^a National Center for Public Health   (Georgia)

^b Chisinau City Infectious Diseases Hospital for Children   (Moldova)

^c Chisinau Municipal Hospital for Children   (Moldova)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

case control; Moldova; rotavirus; surveillance; vaccine effectiveness

Indexed keywords

ROTAVIRUS VACCINE; VACCINE;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFANT; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; MALE; MOLDOVA; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS INFECTION; TREND STUDY; VACCINATION; VIRAL GASTROENTERITIS; EPIDEMIOLOGICAL MONITORING; GASTROENTERITIS; HERD IMMUNITY; IMMUNOLOGY; PREVENTIVE HEALTH SERVICE; ROTAVIRUS; ROTAVIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA; VACCINE IMMUNOGENICITY; VIROLOGY;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; IMMUNITY, HERD; IMMUNIZATION PROGRAMS; IMMUNOGENICITY, VACCINE; INFANT; MALE; MOLDOVA; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINE POTENCY;

EID: 84965168520     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1209     Document Type: Article

References (18)

1. Tate JE, Burton AH, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirusassociated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and metaanalysis. Lancet Infect Dis 2012; 12:136-41.
2. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151-61.
3. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015; 385:430-40.
4. Yen C, Tate JE, Hyde TB, et al. Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother 2014; 10:1436-48.
5. World Health Organization. Generic protocols for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. Geneva, Switzerland. 2002. Available at: http://apps.who.int/iris/bitstream/10665/67743/1/WHO-V-B-02.15-eng.pdf.
6. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990; 22:259-67.
7. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley, 2000.
8. Soares-Weiser K, Maclehose H, Bergman H, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2012; 11: CD008521.
9. de Palma O, Cruz L, Ramos H, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010; 340: c2825.
10. Justino MC, Linhares AC, Lanzieri TM, et al. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belem, Brazil. Pediatr Infect Dis J 2011; 30: 396-401.
11. Patel MM, Patzi M, Pastor D, et al. Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ 2013; 346:f3726.
12. Ichihara MY, Rodrigues LC, Teles Santos CA, et al. Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study. Vaccine 2014; 32:2740-7.
13. Cotes-Cantillo K, Paternina-Caicedo A, Coronell-RodriguezW, et al. Effectiveness of the monovalent rotavirus vaccine in Colombia: A case-control study. Vaccine 2014; 32:3035-40.
14. Gastanaduy PA, Curns AT, Parashar UD, Lopman BA. Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA 2013; 310:851-3.
15. Yen C, Armero Guardado JA, Alberto P, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30(1 suppl):S6-10.
16. Buttery JP, Lambert SB, Grimwood K, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's national childhood vaccine schedule. Pediatr Infect Dis J 2011; 30(1 suppl):S25-9.
17. Paulke-Korinek M, Kundi M, Rendi-Wagner P, et al. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011; 29:2791-6.
18. Standaert B, Gomez JA, Raes M, Debrus S, Velazquez FR, Postma MJ. Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed data. PLoS One 2013; 8:e53864.